AM
AETHLON MEDICAL INC
SEC filingBiotechnology · San Diego, CA
Amount raised$2.2Msold at filing
Total offering$2.2M
Investors in the raise1count reported to the SEC
FiledDec 23, 2025first sale Dec 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Chetan S. Shah, M.D.Director
James B. FrakesExecutive Officer, Director
Edward G. BroennimanDirector
Nicolas S. GikakisDirector
Angela G. RossettiDirector
Executive officers, directors and promoters as listed on the Form D.